Ropes & Gray represented Sanofi as it participated in AgomAb Therapeutics’ $89 million Series D financing round. AgomAb is an Antwerp, Belgium-based biopharma company focused on achieving disease modification by modulating fibrosis and regeneration in chronic indications such as fibrostenosing Crohn’s disease and idiopathic pulmonary fibrosis. The transaction was announced on October 25.
The Ropes & Gray team included strategic transactions associate Courtney Sy and venture capital and emerging companies partner Rajarshi Banerjee.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.